← back to ranking

BMRN · BioMarin Pharmaceutical Inc.

Biotechnology · mkt cap $10.3B · calls: Q1 FY2026 vs Q4 FY2025
3.0 conviction · conf-adj 3

conf –

triage_only:3.0

Enthusiasm latest / prev ()

No AI/ML; focus on Amicus integration, rare-disease drugs, and trials.